Dabigatran etixilate and traumatic brain injury: Evolving anticoagulants require evolving care plans

Table 1 Traumatic brain injury, non-traumatic brain injury and acute care surgery patients on Dabigatran

	TBI	nonTBI	ACS	Total
n	9	10	9	28
Age (yr)	83.4 (8.48)	73.6 (11.6)	76 (8.87)	77.14 (10.5)
M:F	4 M: 5 F	5 M: 5 F	6 M: 3 F	15 M: 13 F
INR	1.69 (0.43)	1.31	1.31	1.451
PTT (s)	54.55 (18.09)	48.05 (33.18)	371	50.351
Concurrent AntiPlatelet	5	2	4	11
Hemodialysis	2	3	1	6
Factor VII	2	2	1	5
Mortality	2	1	3	6

¹Median data was used due to outliers. TBI: Traumatic brain injury; PTT: Partial thromboplastin time.

Table 2 Data of patients with traumatic brain injury

Case	Age, yr	LOS	iLOS	INR	PTT	Anti-Platelet	CrCl	HD	VIIa	FFP	Anti-Platelet	Mortality
1	94	4	3	1.6	61.3	Y	24.1	N	N	Y	Y	N
2	83	1	1	2.5	69	Y	45.6	N	N	N	N	Y
3	79	2	0	1.6	54.3	N	49.8	N	N	N	N	N
4	89	6	3	1.4	35.7	N	40.2	N	N	Y	N	N
5	86	35	5	1.8	50.7	Y	32.4	Y	Y	Y	Y	N
6	64	3	2	1.7	57	Y	99	N	N	Y	N	N
7	88	1	1	1.8	61	N	61.3	N	N	N	N	Y
8	86	2	1	0.9	20	N	46	N	N	Y	N	N
9	82	4	2	1.9	82	Y	46.4	Y	Y	Y	Y	N

LOS: Length of stay; iLOS: Intensive care length of stay; PTT: Partial thromboplastin time.